Blood Biomarker for Early Blood Brain Barrier Disruption in Ischemic Stroke
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 13/660,675, filed Oct 25, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,599,625 | Blood Biomarker for Early Blood Brain Barrier Disruption in Ischemic Stroke In force · High confidence | STC.UNM | In force | High confidence | ||
| US 10,591,491 | Blood Biomarker for Early Blood Brain Barrier Disruption in Ischemic Stroke In force · Medium confidence | STC.UNM | In force | Medium confidence | ||
| US 9,606,129 | Blood Biomarker for Early Blood Brain Barrier Disruption in Ischemic Stroke In force · Medium confidence | STC.UNM | In force | Medium confidence | ||
| US 10,254,295 | Blood Biomarker for Early Blood Brain Barrier Disruption in Ischemic Stroke In force · High confidence | STC.UNM | In force | High confidence | ||
| Application 13/660,675 | Blood Biomarker for Early Blood Brain Barrier Disruption in Ischemic Stroke Abandoned Abandoned Dec 10, 2014 | STC.UNM | Abandoned | Abandoned Dec 10, 2014 |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by STC.UNM.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.